Veterans Community Care Scheduling Improvement Act

**What Happened:** HR3482, the Veterans Community Care Scheduling Improvement Act, was reported (Amended) by the House Committee on Veterans' Affairs on March 30, 2026, and placed on the Union Calendar (Calendar No. 496). The bill mandates that within one year of enactment, the VA Secretary must establish an online IT system allowing VA schedulers to view, search, sort, and book appointments for veterans with non-Department healthcare providers participating in the Veterans Community Care Program. The bill had a mark-up session and voice vote on February 12, 2026, indicating active committee-level momentum. A single sponsor (Rep. Barrett, R-MI) plus one cosponsor shows moderate bipartisan engagement, but not the highest-priority legislation. **The Money Trail:** HR3482 is an authorization bill—it mandates a new program but does NOT appropriate any specific dollar amount. The VA will need to fund the IT system development and ongoing operations through its existing appropriations or request new funding in the FY2027 budget. The Congressional Budget Office (CBO) would need to score the cost, but no score is provided. The key market mechanism is not direct government spending but rather the expansion of demand for private healthcare services. By making it easier for VA schedulers to refer veterans to community care, the bill increases patient volume flowing to private labs, hospitals, and clinics, generating incremental revenue for those providers without a direct line-item from the bill. **Structural Winners and Losers:** The primary beneficiaries are diagnostic laboratory companies $DGX (Quest) and $LH (Labcorp). Lab work is high-volume, relatively low-cost, and frequently referred to community care—expanded scheduling directly increases referral volume. Hospital chains $HCA and $UHS benefit from increased outpatient and surgical referrals filling existing capacity. $AMN benefits from the staffing demand created by scaling community care capacity. Losers are not directly present here—the bill does not cut VA facilities or private provider reimbursement. The companion Presidential Memorandum on April 20, 2026, regarding DPA actions on energy infrastructure has no direct connection to this healthcare bill and does not amplify or conflict with it. **Real Market Data Analysis:** As of April 29, 2026, $DGX trades at $195.05, down 4.39% over 7 days but essentially flat over 30 days (-0.24%). $LH is at $259.57, down 4.79% over 7 days and 1.75% over 30 days. Both lab stocks have pulled back from recent highs, presenting a potential entry point if the VA community care expansion gains traction. $HCA has dropped 8.36% in the last week to $431.92 and 8.46% over 30 days, while $UHS dropped 10.06% in 7 days to $162.54, well below its 52-week high of $246.33. These sharp declines in hospital stocks are a broader market phenomenon (likely sector rotation or earnings concerns), not related to this bill. $AMN (+0.1% 7-day, +10.68% 30-day) has bucked the trend, suggesting staffing demand is already being priced in. **Timeline:** The bill has cleared the House committee and is on the Union Calendar, awaiting a floor vote in the House. If passed, it must go to the Senate. A companion bill has not been introduced in the Senate. The timeline for enactment is uncertain—likely 6-12 months if it gains floor time. Implementation of the scheduling system would take one year post-enactment.